Related Experiment Video

Updated: Sep 30, 2026

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

Oncolysis of human gastric cancers by an E1B 55 kDa-deleted YKL-1 adenovirus

Boyoung Lee1, Jene Choi, Jaesung Kim

  • 1Department of Microbiology, University of Ulsan College of Medicine, P.O. Box 145, 138-736, Seoul, South Korea.

Cancer Letters
|August 10, 2002
PubMed

Insights

This study shows that the YKL-1 adenovirus effectively kills human gastric cancer cells. This oncolytic virus works independently of p53 status, offering a new treatment option for gastric cancer.

Area of Science:

  • Oncolytic virology
  • Gastroenterology
  • Cancer biology

Background:

  • Advanced gastric cancer lacks effective treatments.
  • Recombinant adenoviruses like YKL-1 show promise against p53-deficient cancers.
  • Selective viral replication in cancer cells is a key therapeutic goal.

Purpose of the Study:

  • To investigate the efficacy of YKL-1 in human gastric cancer cells.
  • To determine if YKL-1 replication and cytotoxicity are p53-dependent in gastric cancer.
  • To evaluate YKL-1 as a potential therapeutic agent for gastric cancer.

Main Methods:

  • Testing YKL-1 replication and cytolysis across five human gastric cancer cell lines.
  • Assessing p53 expression in the cell lines.
  • Utilizing transmission electron microscopy to observe viral effects.

Main Results:

  • YKL-1 exhibited cytopathic effects in all tested gastric cancer cell lines.
  • The AGS cell line, with functional p53, was 10-fold more sensitive to YKL-1.
  • YKL-1 efficiently replicated and caused cell death in AGS cells, irrespective of p53 status.

Conclusions:

  • YKL-1 demonstrates preferential cytotoxic effects on human gastric cancer cells.
  • The anti-cancer activity of YKL-1 is independent of the p53 pathway.
  • YKL-1 represents a promising oncolytic virus for gastric cancer therapy.

More Related Videos

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...